首页 > 市场调查报告书 > 医疗设备

e保健

市场调查报告书

商品编码

1654633

全球女性科技市场 - 2025 年至 2033 年

Global Femtech Market - 2025-2033

出版日期: 2025年02月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球女性科技市场规模达到 389 亿美元，预计到 2033 年将达到 1,123 亿美元，2025-2033 年预测期内的复合年增长率为 12.6%。

女性科技是医疗保健领域的一个变革性领域，专注于透过创新解决方案满足女性独特的健康需求。它涵盖各种产品和服务，包括诊断工具、穿戴式装置、远距医疗平台和行动应用程序，专门针对女性特定的状况，如产妇健康、月经健康、骨盆和性健康、生育能力、更年期和避孕。

此外，女性科技也解决对女性影响特别严重的一般健康问题，例如骨质疏鬆症和心血管疾病。

市场动态：

驱动因素与约束因素

不断进步的技术

不断进步的技术正在极大地推动女性科技市场的发展。穿戴式健康追踪器、生育监测器和月经健康设备等新型尖端产品的频繁推出，进一步推动了市场扩张。这些进步不仅提高了女性科技解决方案的准确性和功能性，而且还增加了消费者的信任和采用，促进了市场的持续成长。例如，2023 年 12 月，Arva Health 推出了针对女性的家庭生育测试。这项测试可帮助女性监测和追踪她们的荷尔蒙，使她们能够对生殖健康做出明智的选择。

科技公司、医疗保健提供者和新创公司之间的合作正在加速创新，并推动开发更先进、更用户友好的适合女性健康的设备。例如，2024 年 10 月，拜耳与精准护理领域的创新深度科技新创公司 Impli 建立了合作关係。此次合作旨在推动早期研究，同时探索荷尔蒙监测的各种潜在用例，并为 Impli 提供拜耳全球创新生态系统的使用权。因此，预计上述因素将推动市场成长。

生产成本高

预计先进女性科技设备的高成本将限制大量潜在消费者的取得能力，从而阻碍女性科技市场的发展。由于许多女性科技解决方案（尤其是穿戴式装置和专门的健康设备）价格昂贵，因此并非所有用户都能负担得起，尤其是在新兴市场或低收入者中。这种价格障碍可能会降低采用率，因为消费者可能会犹豫是否要投资这些没有明显、直接利益的产品。此外，高昂的成本可能会限制医疗保健提供者和保险公司广泛提供这些解决方案的能力，从而进一步限制市场成长。

HeraMED
Flo Health Inc.
Allara Health
Bloomlife
Syrona Health
Joylux, Inc.
Coroflo Ltd.
Bonzun
Natural Cycles USA Corp
Similar data will be provided for each market player.
雅典娜女性科技公司
- 管道产品描述
- 产品关键绩效指标 (KPI)
- 主要活动
- 市场进入时间表
- 产品渗透率
- 销售估计和预测
赫博纽特拉
兰花生命科学
印度世界
Aushadhi 草药
将为每个市场参与者提供类似的资料。

第 12 章：附录

简介目录

Product Code: PH9084

The global femtech market reached US$ 38.90 billion in 2024 and is expected to reach US$ 112.30 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.

FemTech is a transformative sector within healthcare that focuses on addressing women's unique health needs through innovative solutions. It encompasses various products and services, including diagnostic tools, wearables, telemedicine platforms, and mobile applications that cater specifically to female-specific conditions such as maternal health, menstrual health, pelvic and sexual health, fertility, menopause, and contraception.

Moreover, FemTech also addresses general health issues that disproportionately affect women, such as osteoporosis and cardiovascular diseases.

Market Dynamics: Drivers & Restraints

Rising Technological Advancements

Rising technological advancements are significantly driving the femtech market. The frequent launch of new, cutting-edge products, such as wearable health trackers, fertility monitors, and menstrual health devices, is further fueling market expansion. These advancements not only improve the accuracy and functionality of femtech solutions but also increase consumer trust and adoption, contributing to the continued growth of the market. For instance, in December 2023, Arva Health launched home fertility tests for women. This test helps women monitor and track their hormones, thus empowering them to make informed choices about their reproductive health.

Collaborations between tech companies, healthcare providers, and startups are accelerating innovation and enabling the development of more advanced, user-friendly devices tailored to women's health. For instance, in October 2024, Bayer entered into a partnership with Impli, an innovative, deep-tech start-up in precision care. The partnership is intended to advance early-stage research while exploring a variety of potential use cases for hormone monitoring and providing Impli with access to Bayer's global innovation ecosystem. Thus, the above factors are expected to drive the market growth.

High production costs

High costs associated with advanced femtech devices are expected to hinder the femtech market by limiting accessibility for a large segment of potential consumers. As many femtech solutions, particularly wearables and specialized health devices can be expensive, they may not be affordable for all users, especially in emerging markets or among lower-income populations. This price barrier can slow down adoption rates, as consumers may be hesitant to invest in these products without clear, immediate benefits. Additionally, the high costs may limit the ability of healthcare providers and insurers to offer these solutions widely, further restricting the market growth.

Segment Analysis

The global femtech market is segmented based on type, application, end-user, and region.

Type:

Devices segment is expected to dominate the global femtech market share

The devices segment is expected to dominate the femtech market due to the rising demand for innovative health monitoring tools tailored to women's needs. Additionally, advances in wearable technology, such as fertility trackers, pregnancy monitoring devices, and menstrual health gadgets, are driving the segment's growth. Several companies and organizations are introducing advanced devices to track and monitor women's health conditions. For instance, in June 2024, Noise launched new women's health tracking features for its smart ring, Luna. This update aims to offer personalized menstrual health insights and predictions, helping women with various menstrual patterns better understand their health.

As consumers are increasingly seeking personalized, at-home healthcare solutions, the convenience and accessibility of these devices are creating more demand for these devices. Companies are collaborating to introduce advanced devices that help individuals track their health and to incorporate advanced features in the existing devices. For instance, in February 2023, Samsung Electronics and Natural Cycles entered into a partnership to bring advanced temperature-based menstrual cycle tracking capabilities to the Galaxy Watch5 series. Furthermore, continuous technological improvements in device accuracy, user experience, and integration with digital health platforms are expected to further strengthen the dominance of the devices segment in the femtech market.

Geographical Analysis

North America is expected to hold a significant position in the global femtech market share

North America holds a major portion of the femtech market and is expected to dominate the market during the forecast period. This is due to consumers' growing adoption of femtech products and services. The rising adoption and significant investment in both healthcare and technology are additional factors contributing to the region's market growth.

Companies are introducing the latest and most advanced solutions with the growing demand and supporting women's health. For instance, in December 2024, ConTIPI Medical and EVERSANA announced the U.S. commercial launch of ProVate, a new non-surgical device for women experiencing pelvic organ prolapse (POP). It is a ready-to-use, disposable device for patients' at-home use, and is now available for physicians across the U.S. to prescribe

The region's advanced healthcare infrastructure, along with a focus on women's health, supports the rapid growth of femtech innovations. Additionally, increasing R&D funding from both private and public sectors is accelerating the development of advanced solutions tailored to the needs of women, positioning North America in the dominant position.

Competitive Landscape

The major global players in the femtech market include Chiaro Technology Ltd., HeraMED, Flo Health Inc., Allara Health, Bloomlife, Syrona Health, Joylux, Inc., Coroflo Ltd., Bonzun, and Natural Cycles USA Corp among others.

Key Developments

In November 2024, PatientsLikeMe (PLM) launched Ella, an AI assistant to help women manage their health, powered by the generative AI platform Ema.
30 May 2024 - UNFPA, the United Nations Sexual and Reproductive Health Agency, launched a groundbreaking initiative to help organizations enhance their employees' reproductive health using the world's first sexual and reproductive health ESG indicators.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Femtech Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. High production costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Software
6.4. Services
6.5. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Women's Mental Health and Well-being*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Reproductive Health
7.4. Women's Geriatric Health
7.5. Oncology
7.6. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diagnostic Centers
8.4. Fertility Centers
8.5. Cancer Centers
8.6. Home Care
8.7. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

11.1. Chiaro Technology Ltd.*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio
  - 11.1.2.1. Product Description
  - 11.1.2.2. Product Key Performance Indicators (KPIs)
  - 11.1.2.3. Historic and Forecasted Product Sales
  - 11.1.2.4. Product Sales Volume
- 11.1.3. Financial Overview
  - 11.1.3.1. Company Revenue's
  - 11.1.3.2. Geographical Revenue Shares
  - 11.1.3.3. Revenue Forecasts
- 11.1.4. Key Developments
  - 11.1.4.1. Mergers & Acquisitions
  - 11.1.4.2. Key Product Development Activities
  - 11.1.4.3. Regulatory Approvals etc.
- 11.1.5. SWOT Analysis
11.2. HeraMED
11.3. Flo Health Inc.
11.4. Allara Health
11.5. Bloomlife
11.6. Syrona Health
11.7. Joylux, Inc.
11.8. Coroflo Ltd.
11.9. Bonzun
11.10. Natural Cycles USA Corp
*Similar data will be provided for each market player.

Emerging Market Players

11.11. Athena Feminine Technologies, Inc.
- 11.11.1. Pipeline Products Description
- 11.11.2. Product Key Performance Indicators (KPIs)
- 11.11.3. Key Activities
- 11.11.4. Market Entry Timelines
- 11.11.5. Product Penetration Rate
- 11.11.6. Sales Estimation and Projections
11.12. Herbo Nutra
11.13. Orchid Lifesciences
11.14. Indo-World
11.15. Aushadhi Herbal
*Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE